Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maris

Showing results (131-140 of 458) with videos related to

Pageof 46
Sort By:
Pediatric Blood & Cancer|May 4, 2011
Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing programChristopher L Morton, John M Maris, Stephen T Keir, et al.
Medical and Pediatric Oncology|December 7, 2000
Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomasM D Hogarty, X Liu, C Guo, et al.
Neuro-Oncology|September 11, 2019
Immunotherapy for pediatric brain tumors: past and presentJessica B Foster, Peter J Madsen, Meenakshi Hegde, et al.
Scientific Reports|October 4, 2024
Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumorsBo Cheng, Wanqi Fang, Steven Pastor, et al.
Molecular Cancer Therapeutics|November 7, 2025
Defining the functional role and potential as an immunotherapeutic target of ALCAM in neuroblastomaJarrett Lindsay, Jonathan Gaither, David Groff, et al.
Pediatric Blood & Cancer|June 2, 2011
Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, John M Maris, et al.
Bone Marrow Transplantation|November 24, 2004
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioningM E D Flowers, F Traina, B Storer, et al.
Pediatric Blood & Cancer|July 9, 2015
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, John M Maris, et al.
Genomics|July 15, 1996
Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3J M Maris, S J Jensen, E P Sulman, et al.
Pediatric Blood & Cancer|January 31, 2006
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastomaJulia A Messina, Su-Chun Cheng, Benjamin L Franc, et al.
Pageof 46

Showing results (131-140 of 458) with videos related to

Sort By:
Pageof 46
Pediatric Blood & Cancer|May 4, 2011
Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing programChristopher L Morton, John M Maris, Stephen T Keir, et al.
Medical and Pediatric Oncology|December 7, 2000
Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomasM D Hogarty, X Liu, C Guo, et al.
Neuro-Oncology|September 11, 2019
Immunotherapy for pediatric brain tumors: past and presentJessica B Foster, Peter J Madsen, Meenakshi Hegde, et al.
Scientific Reports|October 4, 2024
Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumorsBo Cheng, Wanqi Fang, Steven Pastor, et al.
Molecular Cancer Therapeutics|November 7, 2025
Defining the functional role and potential as an immunotherapeutic target of ALCAM in neuroblastomaJarrett Lindsay, Jonathan Gaither, David Groff, et al.
Pediatric Blood & Cancer|June 2, 2011
Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, John M Maris, et al.
Bone Marrow Transplantation|November 24, 2004
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioningM E D Flowers, F Traina, B Storer, et al.
Pediatric Blood & Cancer|July 9, 2015
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, John M Maris, et al.
Genomics|July 15, 1996
Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3J M Maris, S J Jensen, E P Sulman, et al.
Pediatric Blood & Cancer|January 31, 2006
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastomaJulia A Messina, Su-Chun Cheng, Benjamin L Franc, et al.
Pageof 46